Novartis Ag

Novartis Pharma Gmbh

Michael Ausborn

Olivier Lambert

Oskar Nagele

Markus Ahlheim

Marc Riemenschnitter

David Bodmer

Holger Petersen

Jean-Daniel Bonny

Rolf Loeffler

Laurent Marchal

Thomas Kissel

Oliver Lambert

Microparticles consisting of (a) a matrix with a mixture of (a1) at least one hydrophobic, biologically degradable polymer and (a2) optionally at least one water-soluble polymer, (b) a pharmaceutical active ingredient distributed in the matrix, and (c) in addition at least one water-insoluble, surface-active substance from the group of lecithins and phospholipids, distributed in the matrix, and a three-phase emulsion process for their preparation.

Pharmaceutical microparticles

Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles.

Microparticles comprising somatostatin analogues

An emulsion-based method of microencapsulating an active agent wherein a water-in-oil emulsion, containing a matrix-forming polymer and an active agent, is dispersed in an aqueous external phase to form a microencapsulated product.

Organic compounds

Growing community of inventors

Lorrach, Germany

Michael Ausborn